Literature DB >> 23553017

Lineage depletion of stromal vascular fractions isolated from human adipose tissue: a novel approach towards cell enrichment technology.

S Indumathi1, Rashmi Mishra, R Harikrishnan, J S Rajkumar, Neha Kantawala, M Dhanasekaran.   

Abstract

The therapeutic rationale for tissue repair and regeneration using stem cells is at its infancy and needs advancement in understanding the role of individual component's innate capability. As stem cells of adipose tissue reside in a more heterogeneous population of stromal vascular fractions, cell separation or sorting becomes an eminent step towards revealing their unique properties. This study elucidates the comparative efficacy of lineage depleted adipose derived stromal vascular fraction (SVF) and their innate ability using magnetic activated cell sorter (MACS). To this end, isolated SVF from human adipose tissue was lineage depleted according to the manufacturer's instructions using specific antibody cocktail through MACS. The enriched lineage negative (lin-) and lineage positive (lin+) cell fractions were cultured, phenotypically characterized for the panel of cell surface markers using flowcytometry and subjected to osteoblastic and adipogenic differentiation. The expression profile obtained for lin- cells was CD34-/CD45-/HLADR-/CD49d-/CD140b-/CD31-/CD90+/CD105+/CD73+/CD54+/CD166+/CD117- when compared to Lin+ cells expressing CD34+/CD45+/HLADR-/CD49d-/CD140b+/CD31-/CD90+/CD105+/CD73+/CD54+/CD166+/CD117+ (CD-cluster of differentiation). These results, thus, advances our understanding on the inherent property of the individual cell population. Furthermore, both the fractions exhibited mesodermal lineage differentiation capacity. To conclude, this research pursuit rationalized the regenerative therapeutic applicability of both lin- and lin+ cultures of human adipose tissue for disorders of mesodermal, haematological and vascular origin.

Entities:  

Year:  2013        PMID: 23553017      PMCID: PMC3918258          DOI: 10.1007/s10616-013-9556-4

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  21 in total

Review 1.  Adipose tissue-derived therapeutics.

Authors:  Jeffrey M Gimble
Journal:  Expert Opin Biol Ther       Date:  2003-08       Impact factor: 4.388

2.  Surface antigenic profiling of stem cells from human omentum fat in comparison with subcutaneous fat and bone marrow.

Authors:  M Dhanasekaran; S Indumathi; A Kanmani; R Poojitha; K M Revathy; J S Rajkumar; D Sudarsanam
Journal:  Cytotechnology       Date:  2012-02-01       Impact factor: 2.058

3.  A comprehensive study on optimization of proliferation and differentiation potency of bone marrow derived mesenchymal stem cells under prolonged culture condition.

Authors:  M Dhanasekaran; S Indumathi; R P Lissa; R Harikrishnan; J S Rajkumar; D Sudarsanam
Journal:  Cytotechnology       Date:  2012-06-23       Impact factor: 2.058

4.  High gradient magnetic cell separation with MACS.

Authors:  S Miltenyi; W Müller; W Weichel; A Radbruch
Journal:  Cytometry       Date:  1990

5.  Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue.

Authors:  Susanne Kern; Hermann Eichler; Johannes Stoeve; Harald Klüter; Karen Bieback
Journal:  Stem Cells       Date:  2006-01-12       Impact factor: 6.277

6.  The use of a panel of monoclonal antibodies to enrich circulating breast cancer cells facilitates their detection.

Authors:  Gudrun Hager; Dan Cacsire-Castillo Tong; Ingrid Schiebel; Günther A Rezniczek; Rafal Watrowski; Paul Speiser; Robert Zeillinger
Journal:  Gynecol Oncol       Date:  2005-08       Impact factor: 5.482

7.  Detection and quantification of circulating tumor cells in mouse models of human breast cancer using immunomagnetic enrichment and multiparameter flow cytometry.

Authors:  Alison L Allan; Sharon A Vantyghem; Alan B Tuck; Ann F Chambers; Ian H Chin-Yee; Michael Keeney
Journal:  Cytometry A       Date:  2005-05       Impact factor: 4.355

8.  Multilineage cells from human adipose tissue: implications for cell-based therapies.

Authors:  P A Zuk; M Zhu; H Mizuno; J Huang; J W Futrell; A J Katz; P Benhaim; H P Lorenz; M H Hedrick
Journal:  Tissue Eng       Date:  2001-04

9.  Human adipose tissue is a source of multipotent stem cells.

Authors:  Patricia A Zuk; Min Zhu; Peter Ashjian; Daniel A De Ugarte; Jerry I Huang; Hiroshi Mizuno; Zeni C Alfonso; John K Fraser; Prosper Benhaim; Marc H Hedrick
Journal:  Mol Biol Cell       Date:  2002-12       Impact factor: 4.138

10.  Stromal vascular progenitors in adult human adipose tissue.

Authors:  Ludovic Zimmerlin; Vera S Donnenberg; Melanie E Pfeifer; E Michael Meyer; Bruno Péault; J Peter Rubin; Albert D Donnenberg
Journal:  Cytometry A       Date:  2010-01       Impact factor: 4.355

View more
  4 in total

1.  Labeling of Breast Cancer Patient-derived Xenografts with Traceable Reporters for Tumor Growth and Metastasis Studies.

Authors:  Colton Hanna; Letty Kwok; Jessica Finlay-Schultz; Carol A Sartorius; Diana M Cittelly
Journal:  J Vis Exp       Date:  2016-11-30       Impact factor: 1.355

2.  Immunophenotypic comparison of heterogenous non-sorted versus sorted mononuclear cells from human umbilical cord blood: a novel cell enrichment approach.

Authors:  S Indumathi; R Harikrishnan; J S Rajkumar; M Dhanasekaran
Journal:  Cytotechnology       Date:  2013-12-20       Impact factor: 2.058

Review 3.  Development of Synthetic and Natural Materials for Tissue Engineering Applications Using Adipose Stem Cells.

Authors:  Yunfan He; Feng Lu
Journal:  Stem Cells Int       Date:  2016-02-10       Impact factor: 5.443

4.  A short-term plastic adherence incubation of the stromal vascular fraction leads to a predictable GMP-compliant cell-product.

Authors:  Stephan Born; Max Johannes Dörfel; Philip Hartjen; Seyed Ali Haschemi Yekani; Julia Luecke; Juliane Katharina Meutsch; Julie Katharina Westphal; Moritz Birkelbach; Robert Köhnke; Ralf Smeets; Michael Krueger
Journal:  Bioimpacts       Date:  2019-03-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.